A new study has found grapefruit could hold the key to tackling diabetes.
Naringenin, an antioxidant derived from the bitter flavor of grapefruits and other citrus fruits, may cause the liver to break down fat while increasing insulin sensitivity, a process that naturally occurs during long periods of fasting.
Diabetic Diet Insulin : Sugar and Food
Encyclopedia section of medindia briefly explains about Insulin - Sugar and Food
Advertisement
Scientists from the Hebrew University of Jerusalem and Massachusetts General Hospital (MGH) report that naringenin activates a family of small proteins, called nuclear receptors, causing the liver to break down fatty acids.
In fact, the compound seems to mimic the actions of other drugs, such as the lipid-lowering Fenofibrate and the anti-diabetic Rosiglitazone, offering the advantages of both.
![Blood Sugar Chart]( "Blood Sugar Chart")
The blood sugar chart gives you the fasting glucose values and glucose tolerance test values for normal people and people with early diabetes and established diabetes. Also use the calculator to find out if you have diabetes.
If the results of this study extend to human patients, this dietary supplement could become a staple in the treatment of hyperlipidemia, type-2 diabetes, and perhaps metabolic syndrome.
"It is a fascinating find. We show the mechanism by which naringenin increases two important pharmaceutical targets, PPARa and PPAR?, while blocking a third, LXRa. The results are similar to those induced by long periods of fasting," said Yaakov Nahmias, of the Hebrew University of Jerusalem the paper's senior author.
The report appears in this week issue of the online journal PLoS ONE.
Source: ANI
Blood Sugar Chart
The blood sugar chart gives you the fasting glucose values and glucose tolerance test values for normal people and people with early diabetes and established diabetes. Also use the calculator to find out if you have diabetes.
Advertisement
If the results of this study extend to human patients, this dietary supplement could become a staple in the treatment of hyperlipidemia, type-2 diabetes, and perhaps metabolic syndrome.
"It is a fascinating find. We show the mechanism by which naringenin increases two important pharmaceutical targets, PPARa and PPAR?, while blocking a third, LXRa. The results are similar to those induced by long periods of fasting," said Yaakov Nahmias, of the Hebrew University of Jerusalem the paper's senior author.
The report appears in this week issue of the online journal PLoS ONE.
Source: ANI
Advertisement
Advertisement
|
Advertisement
Recommended Reading
Latest Diabetes News
Type 2 diabetes mice injected with beta cells with increased CD63 protein marker production had their blood sugar levels restored to normal.
Good news to children with diabetes: New artificial pancreas can help improve blood sugar control in kids.
New study reveals the link between pre-sleep light exposure and gestational diabetes mellitus in pregnant women.
Spinal cord stimulation delivers electrical stimulation to the spinal cord to cut off pain signals to the brain and may ease pain associated with diabetic neuropathy.
Cognitive behavioral therapy delivered via smartphone app was found to lower blood sugar levels in type 2 diabetes people.